Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2/3 2Phase NA 1Phase 2 1Phase 1 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 34Lung Neoplasms 11Neoplasms 4Adenocarcinoma of Lung 4Brain Neoplasms 3Adenocarcinoma, Bronchiolo-Alveolar 3Neoplasm Metastasis 2NSCLC 2Urinary Bladder Neoplasms 1Thoracic Neoplasms 1Stage IV EGFR Mutated Non-Small Cell Lung Cancer 1Squamous Cell Carcinoma of Head and Neck 1Respiratory Tract Diseases 1Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non-small Cell Lung Cancer 1Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1Head and Neck Neoplasms 1EGFR Tyrosine Kinase Inhibitors Plus VEGFR Inhibitors 1Carcinoma 1Breast Neoplasms 1Advanced Non-small Cell Lung Cancer 1Adenocarcinoma 1

Interventions

osimertinib 3Vinorelbine 3Pemetrexed 3Cisplatin 3Carboplatin 3Gemcitabine 2Gefitinib 2Docetaxel 2CP protocol 2rezivertinib 1pembrolizumab 1aumolertinib 1Taxes 1Paclitaxel 1HMPL-013 1HM781-36B 1Erlotinib Hydrochloride 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × NSCLC × Gefitinib × Clear all
NCT03866499 2024-08-07

A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients

Beta Pharma, Inc.

Phase 3 Active not recruiting
369 enrolled
Thoracic

NSCLC

NCT03656393 2018-09-04

RCTACSCNSCLC

Shenzhen People's Hospital

Phase 3 Unknown
48 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡